Analyst Ratings for Biohaven Pharma (BHVN)
BHVN Rating Summary
BHVN Price Target Summary
- Highest: $42.00 (Baird)
- Lowest: $9.00 (Bernstein SocGen Group)
- Average: $20.82
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$20.82 (+32.3%)
* Over Last 12-Mos
Rating Score: 6.8 / 10
Percentile Rank: 73%
Avg. $ Target:
$20.82 (+32.3%)
* Over Last 12-Mos
Rating Score: 6.8 / 10
Percentile Rank: 73%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/29/2026 | BofA Securities | Jason Gerberry | Downgrade | Underperform (Neutral) |
11.00 (12.00) |
15.83 (15.74) |
-0.57% | Details |
| 4/13/2026 | Canaccord » Updated 8/28/2026 |
Sumant Kulkarni | New Coverage | Buy (N/A) |
21.00 (N/A) |
9.17 (15.74) |
71.65% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
